This study is a randomized controlled trial that compares 3 self-monitoring approaches for weight loss. GoalTracker is a standalone, technology-based intervention using a commercial smartphone app (MyFitnessPal) and email. The investigators hypothesize that the group that delays diet tracking and receives additional intervention components (weekly personalized feedback, skills training, and action plans) will have greater weight loss at the end of the 12-week intervention and at 6-month followup, compared to (a) an intervention group that simultaneously tracks weight and diet for all 12 weeks and receives the same additional components, and (b) a control group that tracks only diet.
This study will examine whether a digital health intervention (GoalTracker) can promote weight loss among adults who are overweight or obese. Engagement in self-monitoring often declines over time, which is then associated with suboptimal weight loss. Finding ways to improve self-monitoring engagement, particularly in the first month of treatment, is needed. Promoting mastery, self-efficacy, and self-regulatory skills may help with maintaining high engagement. The investigators aim to enroll 105 participants. All groups are asked to self-monitor daily on their smartphone using the free commercial mobile application MyFitnessPal over the course of the 12-week intervention. Specifically, the study aims to... 1. Determine the effect of a Sequential self-monitoring intervention, compared to a Simultaneous self-monitoring intervention on weight change, caloric intake change, and proportion of individuals achieving 5% weight loss. 2. Determine the effect of the Sequential self-monitoring intervention, compared to the Control, on the same variables. 3. Compare self-monitoring engagement by intervention arm. 4. Examine the relation between self-monitoring engagement and weight loss. 5. Investigate theoretical mediators (self-efficacy, mastery, and self-regulation) on the relation between treatment arm and weight change.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
105
\- weigh daily for 3 months and track their weight using the MyFitnessPal mobile app
* track their diet (food and drinks) daily using the MyFitnessPal mobile app * when they are asked to track diet will vary based on the arm
\- these are additional evidence-based intervention components
Duke University
Durham, North Carolina, United States
Change in Weight
Weight will be collected in kilograms using a calibrated digital scale
Time frame: Baseline, 1 month, 3 months
Proportion of Individuals Achieving ≥ 5% Weight Loss
Weight will be collected in kilograms using a calibrated digital scale
Time frame: Baseline to 3 months
Change in Caloric Intake
Caloric intake will will be assessed using the Automated Self-Administered 24-hour Dietary Intake Assessment (ASA24), an online dietary recall tool developed by the National Cancer Institute
Time frame: Baseline, 3 months
Change in Weight at 6 Months
At 6-months (i.e., 3 months post-intervention), self-reported weight will be collected
Time frame: 6 months
Self-Monitoring Engagement
Frequency of self-monitoring weight and diet; Consistency of self-monitoring weight and diet
Time frame: Baseline to 1-month and 3 months
Self-Efficacy
Weight Efficacy Lifestyle Questionnaire (WEL) (20 items) will assess self-efficacy for eating. Separate surveys that were adapted will assess self-efficacy for self-monitoring of diet and weight.
Time frame: Baseline, 1 month, 3 months
Mastery
The Automaticity subscale of The Self-Report Habit Index (SRHI) will assess mastery of self-monitoring diet and weight (4 items each).
Time frame: Baseline, 1 month, 3 months
Self-Regulation
The Three Factor Eating Questionnaire-R18 (TFEQ-R18) (18 items) will assess self-regulation for controlled eating. Separate surveys that were adapted will assess self-regulation for self-monitoring of diet and weight.
Time frame: Baseline, 1 month, 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.